Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease.

Jason Payne,Smriti Sharma,Dexter De Leon,Jun L Lu,Fregenet Alemu,Rasheed A Balogun,Sandra M Malakauskas,Kamyar Kalantar-Zadeh,Csaba P Kovesdy

DOI: https://doi.org/10.1093/ndt/gfr282

IF: 7.1857

2012-01-01

Nephrology Dialysis Transplantation

Abstract:Background. The interrelationship of left ventricular hypertrophy (LVH) with ejection fraction (EF) and their impact on mortality in non-dialysis-dependent chronic kidney disease (NDD-CKD) is unclear. Methods. We examined the associations of EF and LVH with all-cause mortality in a historic cohort of 650 male US veterans with moderate-to-advanced NDD-CKD. EF and LVH were examined both separately and after categorizing patients according to their concomitant EF and presence/absence of LVH. Associations with mortality were examined in Cox models with adjustments for demographics, blood pressure, comorbidities, smoking status, medication use and biochemical characteristics. Results. EF < 30 and 30-50% were associated with higher all-cause mortality compared to EF > 50% even after multivariable adjustments [multivariable adjusted hazard ratio, 95% confidence interval (CI): 2.83 (1.86-4.30) and 1.38 (1.06-1.78), P < 0.001 for linear trend]. LVH in itself was not associated with mortality [multivariable adjusted hazard ratio, 95% CI: 0.83 (0.66-1.05), P = 0.12], but the presence of LVH combined with an EF < 50% was associated with the highest mortality [multivariable adjusted hazard ratios, 95% CI in patients with EF > 50% + LVH, EF <= 50%-LVH and EF <= 50% + LVH, compared to EF > 50%-LVH: 0.84 (0.63-1.13), 1.36 (1.00-1.83) and 1.62 (1.07-2.46)]. Conclusions. Low EF is associated with higher mortality in patients with NDD-CKD. In the presence of a low EF, LVH is also associated with higher mortality. Clinical trials are needed to determine if interventions targeting patients with low EF and LVH can lower mortality in NDD-CKD.